Results 11 to 20 of about 499,109 (301)
New psychoactive substances: a review and updates
Therapeutic Advances in Psychopharmacology, 2020 New psychoactive substances (NPS) are a heterogeneous group of substances. They are associated with a number of health and social harms on an individual and societal level. NPS toxicity and dependence syndromes are recognised in primary care, emergency departments, psychiatric inpatient and community care settings.
Alex J Berry, Derek K. Tracy, David Wood
exaly +4 more sources
Use of psychoactive substances among university students from 2019 to 2020: A systematic review
Brain, Behavior, & Immunity - HealthPsychoactive substances act on the central nervous system producing changes in mental processes, such as perception, consciousness, cognition or mood and emotions.
Gustavo Reis Sampaio +3 more
exaly +3 more sources
Novel psychoactive substance [PDF]
Clinical Medicine, 2021 Editor – We read with interest the article entitled ‘Acute neurological consequences of novel psychoactive substance use: a retrospective review in a large UK hospital’ by Tanti et al .[1][1] The team have effectively highlighted the high rates of psychiatric comorbidity, unemployment,
Mark, Pucci +2 more
openaire +2 more sources
Artists and psychoactive substances use [PDF]
Psychiatriki, 2021 It is a well-established common notion that artists appear to use and abuse psychoactive substances more frequently and heavily than non-artists. The purpose of this study was to investigate if this holds true. The sample consisted of 118 participants, both artists and non-artists.
Patsika, E., Malliori, M.-M.
openaire +3 more sources
Toxicology of Psychoactive Substances
Critical Care Clinics, 2021 A trend in the increasing use of prescription psychoactive drugs (PADs), including antidepressants, antipsychotics, and mood stabilizers, has been reported in the United States and globally. In addition, there has been an increase in the production and usage of illicit PADs and emergence of new psychoactive substances (NPSs) all over the world.
Prisco L. +3 more
openaire +4 more sources
Novel psychoactive substances [PDF]
British Journal of General Practice, 2016 Gilani does well to highlight the increasing and concerning use of novel psychoactive substances (NPS) in the UK.1 We have seen the damaging and unpredictable effects of synthetic cannabinoids in prisons …
L. Orsolini +5 more
openaire +3 more sources
The Use and Impact of Cognitive Enhancers among University Students: A Systematic Review
Brain Sciences, 2021 Introduction: Cognitive enhancers (CEs), also known as “smart drugs”, “study aids” or “nootropics” are a cause of concern. Recent research studies investigated the use of CEs being taken as study aids by university students.
Safia Sharif +3 more
doaj +1 more source
Brain Sciences, 2023 The emergence of glucagon-like peptide-1 receptor agonists (GLP-1 RAs; semaglutide and others) now promises effective, non-invasive treatment of obesity for individuals with and without diabetes.
Davide Arillotta +7 more
doaj +1 more source
Identifying New/Emerging Psychoactive Substances at the Time of COVID-19; A Web-Based Approach
Frontiers in Psychiatry, 2021 COVID-19-related disruptions of people and goods' circulation can affect drug markets, especially for new psychoactive substances (NPSs). Drug shortages could cause a change in available NPS, with the introduction of new, unknown, substances. The aims of
Valeria Catalani +8 more
doaj +1 more source
COVID-19 Pandemic Impact on Substance Misuse: A Social Media Listening, Mixed Method Analysis
Brain Sciences, 2021 The restrictive measures adopted during the COVID-19 pandemic modified some previously consolidated drug use patterns. A focus on social networks allowed drug users to discuss, share opinions and provide advice during a worldwide emergency context.
Davide Arillotta +4 more
doaj +1 more source